Archean Chemical Industries Limited EBIT

The latest EBIT for ACI.BO is $1.5B as of June 2026. That compares with $2.3B in the prior-year period — down 34.1% year over year. That is above the sector sector average of $-25M. Investors often review this figure alongside Archean Chemical Industries Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACI.BO's EBIT moved from $2.3B to $1.5B — a 34.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Archean Chemical Industries Limited's operating scale or balance-sheet position.

Against its sector companies, ACI.BO currently prints $1.5B for EBIT, while the sector average sits near $-25M. That is roughly 6158.8% above the sector mean. Large gaps often invite a closer look at Archean Chemical Industries Limited's growth, margins, and balance sheet.

A EBIT figure of $1.5B for ACI.BO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-25M. Explore the charts below for those layers of context.

After noting ACI.BO's EBIT ($1.5B), review year-over-year change from $2.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.